z-logo
Premium
New NO‐Donors with Antithrombotic and Vasodilating Activities, Part 14 1,3,4‐Triazol‐1‐oles
Author(s) -
Rehse Klaus,
Piechocki Daniela,
Schober Markus,
Scheffler Heike,
Reitner Nora,
Unsöld E.
Publication year - 1996
Publication title -
archiv der pharmazie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.468
H-Index - 61
eISSN - 1521-4184
pISSN - 0365-6233
DOI - 10.1002/ardp.19963291107
Subject(s) - antithrombotic , chemistry , nitric oxide , thrombus , pharmacology , mechanism of action , vasodilation , oxime , stereochemistry , aryl , alkyl , medicinal chemistry , in vitro , biochemistry , organic chemistry , medicine
Five 1,3,4‐triazol‐1‐oles ( 5a—f ) with different alkyl, aryl, and arylalkyl substituents in 2,5‐position were synthesized and tested for their antithrombotic properties. The 2,5‐dimethyl derivative 5a was most active. 2 h after administration of 60 mg/kg to rats thrombus formation by a laser beam was inhibited by 42 % in arterioles and by 33 % in venules. At the same dose the blood pressure of SHR rats was slightly (5%) but significantly decreased even 4 h after application of 5a . This pattern of activities suggests a nitric oxide mediated mechanism of action. 1,1′‐Azo‐bis‐ethanone oxime ( 7 ) — the synthetic precursor of 5a — inhibited the aggregation of blood platelet (Born test) with an IC 50 = 15 μmol/L.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom